NCT04238676 - Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 20, 2020

Primary Completion Date

December 9, 2024

Study Completion Date

December 9, 2024

Conditions

Chronic Low-back Pain

Interventions

DRUG

PP353

active administered by intradiscal injection

OTHER

Placebo

Sham injection

Trial Locations (10)

CGM Research Trust, Christchurch

Gildhøj Privathospital København, Copenhagen

Hospital Vithas Granada, Granada

Hospital Universitario LA PAZ, Madrid

Royal Preston Hospital, Preston

University Hospital Of Wales, Cardiff

University Hospital Coventry & Warwickshire, Coventry

Leeds General Infirmary, Leeds

Oxford University Hospitals NHS Foundation Trust, Oxford

University Hospital Southampton Nhs Foundation Trust, Southampton